- cafead Aug 05, 2020 at 12:22: AM
via The FDA approved a Johnson & Johnson drug for a new class of people with depression disorders Aug. 3 despite concerns about its potential to be abused because it contains a once-popular party drug.
Previously, the drug, Spravato, was only approved for people with treatment-resistant depression. Now people with major depressive disorder with acute suicidal ideation or behavior will be allowed to take the drug.
article source
Previously, the drug, Spravato, was only approved for people with treatment-resistant depression. Now people with major depressive disorder with acute suicidal ideation or behavior will be allowed to take the drug.
article source